Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8DMI

Lymphocytic choriomeningitis virus glycoprotein

Summary for 8DMI
Entry DOI10.2210/pdb8dmi/pdb
EMDB information27539
DescriptorGlycoprotein G1, Glycoprotein G2,Cobalamin adenosyltransferase-like domain-containing protein trimerization tag, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total)
Functional Keywordsviral glycoprotein, arenavirus, lcmv, gp, viral protein
Biological sourceLymphocytic choriomeningitis virus
More
Total number of polymer chains6
Total formula weight212030.28
Authors
Moon-Walker, A.,Hastie, K.M.,Zyla, D.S.,Saphire, E.O. (deposition date: 2022-07-08, release date: 2023-04-12, Last modification date: 2023-05-03)
Primary citationMoon-Walker, A.,Zhang, Z.,Zyla, D.S.,Buck, T.K.,Li, H.,Diaz Avalos, R.,Schendel, S.L.,Hastie, K.M.,Crotty, S.,Saphire, E.O.
Structural basis for antibody-mediated neutralization of lymphocytic choriomeningitis virus.
Cell Chem Biol, 30:403-411.e4, 2023
Cited by
PubMed Abstract: The mammarenavirus lymphocytic choriomeningitis virus (LCMV) is a globally distributed zoonotic pathogen that can be lethal in immunocompromised patients and can cause severe birth defects if acquired during pregnancy. The structure of the trimeric surface glycoprotein, essential for entry, vaccine design, and antibody neutralization, remains unknown. Here, we present the cryoelectron microscopy (cryo-EM) structure of the LCMV surface glycoprotein (GP) in its trimeric pre-fusion assembly both alone and in complex with a rationally engineered monoclonal neutralizing antibody termed 18.5C-M28 (M28). Additionally, we show that passive administration of M28, either as a prophylactic or therapeutic, protects mice from LCMV clone 13 (LCMV) challenge. Our study illuminates not only the overall structural organization of LCMV GP and the mechanism for its inhibition by M28 but also presents a promising therapeutic candidate to prevent severe or fatal disease in individuals who are at risk of infection by a virus that poses a threat worldwide.
PubMed: 36990092
DOI: 10.1016/j.chembiol.2023.03.005
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.26 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon